125 related articles for article (PubMed ID: 30216892)
21. Generation of four myotonic dystrophy type 1 patient iPSC lines (CBRCULi002-A, CBRCULi003-A, CBRCULi004-A, CBRCULi005-A) and a control (CBRCULi001-A) derived from lymphoblastoids cell lines.
Jauvin D; Pierre M; Boutjdir M; Puymirat J; Chahine M
Stem Cell Res; 2023 Mar; 67():103037. PubMed ID: 36739767
[TBL] [Abstract][Full Text] [Related]
22. Modelling the pathogenesis of Myotonic Dystrophy type 1 cardiac phenotype through human iPSC-derived cardiomyocytes.
Spitalieri P; Talarico RV; Caioli S; Murdocca M; Serafino A; Girasole M; Dinarelli S; Longo G; Pucci S; Botta A; Novelli G; Zona C; Mango R; Sangiuolo F
J Mol Cell Cardiol; 2018 May; 118():95-109. PubMed ID: 29551391
[TBL] [Abstract][Full Text] [Related]
23. Generation of induced pluripotent stem cell line (ZZUi0026-A) from a patient with spinocerebellar ataxia type 3.
Fang J; Wang Y; Wang Z; Sun H; Zhang Q; Yang J; Liu Y; Liu H; Shi C; Xu Y; Zhang X; Kan Q
Stem Cell Res; 2021 May; 53():102205. PubMed ID: 34087977
[TBL] [Abstract][Full Text] [Related]
24. Generation of induced pluripotent stem cells (iPSCs) from an infant with catecholaminergic polymorphic ventricular tachycardia carrying the double heterozygous mutations A1855D in RyR2 and Q1362H in SCN10A.
Zhang Y; Li A; Huang CL; Wang G; Wang D
Stem Cell Res; 2019 Aug; 39():101509. PubMed ID: 31382203
[TBL] [Abstract][Full Text] [Related]
25. Establishment of human iPSC line NCCSi003-A from CD34
Fernandes S; Tembe S; Shinde P; Melinkeri S; Kale V; Limaye L
Stem Cell Res; 2018 Mar; 27():1-4. PubMed ID: 29274886
[TBL] [Abstract][Full Text] [Related]
26. Generation of induced pluripotent stem cell line (ZZUi0018-A ) from a patient with spinocerebellar ataxia type 6.
Yang T; Qin J; Zhang Q; Sun H; Wang Z; Yang J; Liu H; Zhang C; Zhang S; Zhang J; Wang Y; Xu Y
Stem Cell Res; 2020 Apr; 44():101777. PubMed ID: 32229428
[TBL] [Abstract][Full Text] [Related]
27. Generation of a human induced pluripotent stem cell line CERAi001-A-6 using episomal vectors.
Wong RCB; Hung SS; Jackson S; Singh V; Khan S; Liang HH; Kearns LS; Nguyen T; Conquest A; Daniszewski M; Hewitt AW; Pébay A
Stem Cell Res; 2017 Jul; 22():13-15. PubMed ID: 28952926
[TBL] [Abstract][Full Text] [Related]
28. Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS).
Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
Stem Cell Res; 2017 Dec; 25():291-295. PubMed ID: 29150092
[TBL] [Abstract][Full Text] [Related]
29. Pluripotent Stem Cells in Disease Modeling and Drug Discovery for Myotonic Dystrophy Type 1.
Bérenger-Currias N; Martinat C; Baghdoyan S
Cells; 2023 Feb; 12(4):. PubMed ID: 36831237
[TBL] [Abstract][Full Text] [Related]
30. iPSC-derived cardiomyocytes from patients with myotonic dystrophy type 1 have abnormal ion channel functions and slower conduction velocities.
Poulin H; Mercier A; Djemai M; Pouliot V; Deschenes I; Boutjdir M; Puymirat J; Chahine M
Sci Rep; 2021 Jan; 11(1):2500. PubMed ID: 33510259
[TBL] [Abstract][Full Text] [Related]
31. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
Cho DH; Tapscott SJ
Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
[TBL] [Abstract][Full Text] [Related]
32. Generation of induced pluripotent stem cell line (ZZUi0012-A) from a patient with Fahr's disease caused by a novel mutation in SLC20A2 gene.
Zhang Q; Li Z; Sun H; Zhang S; Zhang J; Wang Y; Fang H; Xu Y
Stem Cell Res; 2019 Mar; 35():101395. PubMed ID: 30776674
[TBL] [Abstract][Full Text] [Related]
33. Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC.
Aoki T; Ohnishi H; Oda Y; Tadokoro M; Sasao M; Kato H; Hattori K; Ohgushi H
Tissue Eng Part A; 2010 Jul; 16(7):2197-206. PubMed ID: 20146561
[TBL] [Abstract][Full Text] [Related]
34. Generation of induced pluripotent stem cell (iPSC) line from Charcot-Marie-Tooth disease patient with MPZ mutation (CMT1B).
Son D; Kang PJ; Yun W; You S
Stem Cell Res; 2017 Oct; 24():5-7. PubMed ID: 29034895
[TBL] [Abstract][Full Text] [Related]
35. Generation of induced pluripotent stem cell line (ZZUi0013-A) from a 65-year-old patient with a novel MEOX2 gene mutation in Alzheimer's disease.
Wang Y; Sun H; Yang J; Shi C; Liu Y; Xu Y; Zhang J
Stem Cell Res; 2019 Jan; 34():101366. PubMed ID: 30616143
[TBL] [Abstract][Full Text] [Related]
36. Generation of induced pluripotent stem cell line (ZZUi030-A) from a patient with spastic paraplegia type 7.
Zhang Q; Wang Z; Sun H; Chen N; Xu X; Yang J; Gao Y; Wang Y; Xu Y
Stem Cell Res; 2021 Oct; 56():102525. PubMed ID: 34509920
[TBL] [Abstract][Full Text] [Related]
37. Generation of induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient with the pathogenic variant p.Val698Ala in beta-myosin heavy chain (MYH7) gene.
Ross SB; Fraser ST; Nowak N; Semsarian C
Stem Cell Res; 2017 Apr; 20():88-90. PubMed ID: 28395747
[TBL] [Abstract][Full Text] [Related]
38. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
[TBL] [Abstract][Full Text] [Related]
39. Generation of three induced pluripotent stem cell lines from postmortem tissue derived following sudden death of a young patient with STXBP1 mutation.
Yamamoto T; Otsu M; Okumura T; Horie Y; Ueno Y; Taniguchi H; Ohtaka M; Nakanishi M; Abe Y; Murase T; Umehara T; Ikematsu K
Stem Cell Res; 2019 Aug; 39():101485. PubMed ID: 31255830
[TBL] [Abstract][Full Text] [Related]
40. Fuchs' Endothelial Corneal Dystrophy in Patients With Myotonic Dystrophy, Type 1.
Winkler NS; Milone M; Martinez-Thompson JM; Raja H; Aleff RA; Patel SV; Fautsch MP; Wieben ED; Baratz KH
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3053-3057. PubMed ID: 30025114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
